Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety (ME-SMART): a monocentric, controlled, randomized, crossover trial.
Michael ScholzStefan LakaemperKristina KellerAkos DobayAndrea Eva SteuerHans-Peter LandoltThomas KrämerPublished in: Trials (2023)
ClinicalTrials.gov Identifier NCT05585515, released on 18.10.2022; Swiss National Clinical Trial Portal SNCTP000005089, registered on 12 August 2022.